R&D BIONICE
DEAD

Serial Number

79222695

Owner

BIONICE, S.L.U.

Filing Date

Apr 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

R&D BIONICE Trademark

Serial Number: 79222695

R&D BIONICE is a trademark filed by BIONICE, S.L.U. on April 17, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BIONICE, S.L.U.

Parque Tecnológico de Boecillo, P.113

Entity Type: 99

CURIA SPAIN, S.A.U.

Parque Tecnológico de Boecillo,

Entity Type: 98

CRYSTAL PHARMA, S.A.U.

Parque Tecnológico de Boecillo,

Entity Type: 99

Trademark Details

Filing Date

April 17, 2017

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism; pharmaceutical and veterinary active ingredients for treating diseases of the cardiovascular system; pharmaceutical and veterinary active ingredients for treatment of diseases of the skin; pharmaceutical and veterinary active ingredients for treatment of diseases of the respiratory system; pharmaceutical and veterinary active ingredients for treating diseases of the musculoskeletal system; pharmaceutical and veterinary active ingredients for treating diseases of the nervous system; pharmaceutical preparations, namely, antidepressants; sanitary products for medical use; dietetic food and substances for medical or veterinary use; disinfectants; products for destroying vermin; fungicides, herbicides; chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; hormones for medical use; steroids; antihistamines

Custom manufacture of pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism, diseases of the cardiovascular system, diseases of the skin, diseases of the respiratory system, diseases of the musculoskeletal system and diseases of the nervous system; custom manufacture of chemico-pharmaceutical preparations, namely, antidepressants; custom manufacture of sanitary products for medical use; custom manufacture of dietetic food and substances for medical or veterinary use; custom manufacture of disinfectants, products for destroying vermin, fungicides and herbicides; custom manufacture of chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; custom manufacture of hormones for medical use, steroids and antihistamines; processing of pharmaceutical and chemical products

Pharmaceutical research and development; providing medical research information; providing veterinary research information; conducting clinical trials for others relating to pharmaceutical products; laboratory services, namely, analytical laboratory services; analysis and evaluation of product development; design and development of new technology for others in the field of biotechnology, pharmacy and chemistry; provision of information, advice and consultancy relating to all the aforementioned services

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 5, 2026 ADCH
CHANGE OF OWNER RECEIVED FROM IB
Feb 12, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 23, 2019 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 6, 2019 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2019 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 24, 2019 OPNX
NEW REPRESENTATIVE AT IB RECEIVED
May 23, 2019 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 8, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 8, 2019 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 6, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 6, 2018 ABN2
REFUSAL PROCESSED BY IB
Jan 27, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 6, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jan 6, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 19, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 15, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 13, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2017 REPR